| 1 | Cancer | 3.11% | |
| 2 | Study | 1.86% | |
| 3 | Could | 1.24% | |
| 4 | Its | 1.24% | |
| 5 | Patients | 1.24% | |
| 6 | Risk | 1.24% | |
| 7 | Therapy | 1.24% | |
| 8 | New | 1.24% | |
| 9 | Identify | 1.24% | |
| 10 | Dormant | 1.24% | |
| 11 | Show | 1.24% | |
| 12 | ASCO | 1.24% | |
| 13 | Against | 1.24% | |
| 14 | Found | 1.24% | |
| 15 | Cells | 1.24% | |
| 16 | Trimodality | 0.62% | |
| 17 | Strategies | 0.62% | |
| 18 | Performance-Enhancin | 0.62% | |
| 19 | Target | 0.62% | |
| 20 | Proteins | 0.62% | |
| 21 | Effectiveness | 0.62% | |
| 22 | Eliminate | 0.62% | |
| 23 | Smell | 0.62% | |
| 24 | Day | 0.62% | |
| 25 | Boost | 0.62% | |
| 26 | Syndrome | 0.62% | |
| 27 | Higher | 0.62% | |
| 28 | Drugs | 0.62% | |
| 29 | (ARPI) | 0.62% | |
| 30 | Servings | 0.62% | |
| 31 | Fight | 0.62% | |
| 32 | Pathogens | 0.62% | |
| 33 | Berries | 0.62% | |
| 34 | Chief | 0.62% | |
| 35 | (MMAI) | 0.62% | |
| 36 | Utility | 0.62% | |
| 37 | Muscle | 0.62% | |
| 38 | Non-Metastatic | 0.62% | |
| 39 | Multimodal | 0.62% | |
| 40 | Invasive | 0.62% | |
| 41 | Trials | 0.62% | |
| 42 | AMR | 0.62% | |
| 43 | Improvement | 0.62% | |
| 44 | Mutation | 0.62% | |
| 45 | Hypercoagulopathy | 0.62% | |
| 46 | 2nd-Generation | 0.62% | |
| 47 | After | 0.62% | |
| 48 | Receptor | 0.62% | |
| 49 | Pathways | 0.62% | |
| 50 | Factor | 0.62% | |
|
는 분류, 데이터 기준으로 의 기사에서 의 고유명사 데이터를 통해 생성되었습니다.
|
|||